Cargando…

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

The unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in the search for immediate treatment strategies. With no specific drug and not much data available, alternative approaches such as drug repurposing came to the li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niranjan, Vidya, Setlur, Anagha Shamsundar, Karunakaran, Chandrashekar, Uttarkar, Akshay, Kumar, Kalavathi Murugan, Skariyachan, Sinosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346052/ https://www.ncbi.nlm.nih.gov/pubmed/35938064 http://dx.doi.org/10.1007/s11224-022-02020-z

Ejemplares similares

Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs
por: Skariyachan, Sinosh, et al.
Publicado: (2020)

Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies
por: Skariyachan, Sinosh, et al.
Publicado: (2021)

Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies
por: Skariyachan, Sinosh, et al.
Publicado: (2021)

Molecular Docking and Interaction Studies of Identified Abscisic Acid Receptors in Oryza sativa: An In-Silico Perspective on Comprehending Stress Tolerance Mechanisms
por: Niranjan, Vidya, et al.
Publicado: (2021)

Editorial: Computational drug discovery for emerging viral infections
por: Skariyachan, Sinosh, et al.
Publicado: (2023)

MutaXome: A Novel Database for Identified Somatic Variations of In silico Analyzed Cancer Exome Datasets
por: Padmavathi, P, et al.
Publicado: (2022)

Implementation of ensemble machine learning algorithms on exome datasets for predicting early diagnosis of cancers
por: Pasha Syed, Abdu Rehaman, et al.
Publicado: (2022)

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Decision Support System and Web-Application Using Supervised Machine Learning Algorithms for Easy Cancer Classifications
por: Chandrashekar, K, et al.
Publicado: (2023)

Selection of herbal therapeutics against deltatoxin mediated Clostridial infections
por: Skariyachan, Sinosh, et al.
Publicado: (2011)

De Novo Design of Anti-COVID Drugs Using Machine Learning-Based Equivariant Diffusion Model Targeting the Spike Protein
por: Niranjan, Vidya, et al.
Publicado: (2023)

Protocol for the development of coarse-grained structures for macromolecular simulation using GROMACS
por: Niranjan, Vidya, et al.
Publicado: (2023)

Mycobacterium Time-Series Genome Analysis Identifies AAC2′ as a Potential Drug Target with Naloxone Showing Potential Bait Drug Synergism
por: Niranjan, Vidya, et al.
Publicado: (2022)

Design of Novel Coumarin Derivatives as NUDT5 Antagonists That Act by Restricting ATP Synthesis in Breast Cancer Cells
por: Niranjan, Vidya, et al.
Publicado: (2022)

Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2
por: Kumar, K. M., et al.
Publicado: (2023)

Recent Perspectives on Genome, Transmission, Clinical Manifestation, Diagnosis, Therapeutic Strategies, Vaccine Developments, and Challenges of Zika Virus Research
por: Shankar, Apoorva, et al.
Publicado: (2017)

Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity
por: Shrinivasan, Mahesh, et al.
Publicado: (2012)

C-demethylation and 1, 2-amino shift in (E)-2-(1-(3-aminophenyl) ethylidene)hydrazinecarboxamide to (E)-2-(2-aminobenzylidene)hydrazinecarboxamide and their applications
por: Sennappan, M., et al.
Publicado: (2020)

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome
por: Karunakaran, Kalyani B., et al.
Publicado: (2020)

Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
por: Ahmad, Shaban, et al.
Publicado: (2022)

Applying polypharmacology approach for drug repurposing for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2022)

Structure based virtual screening of novel inhibitors against multidrug resistant superbugs
por: Skariyachan, Sinosh, et al.
Publicado: (2012)

Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections
por: Skariyachan, Sinosh, et al.
Publicado: (2019)

Stress-Induced Detoxification Enzymes in Rice Have Broad Substrate Affinity
por: Niranjan, Vidya, et al.
Publicado: (2021)

Computer aided screening and evaluation of herbal therapeutics against MRSA infections
por: Skariyachan, Sinosh, et al.
Publicado: (2011)

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
por: Jung, Christoph, et al.
Publicado: (2022)

Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
por: Mujwar, Somdutt
Publicado: (2021)

Repurposing Positive SARS-CoV-2 Antigen Test Devices for Variant Tracking
por: Urrutikoetxea-Gutierrez, Mikel, et al.
Publicado: (2022)

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2
por: Brüssow, Harald
Publicado: (2022)

Latest SARS evidence
por: Walgate, Robert
Publicado: (2003)

Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs
por: More, Shweta A., et al.
Publicado: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
por: Wambani, Josephine, et al.
Publicado: (2022)

Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
por: Murer, Luca, et al.
Publicado: (2022)

Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
por: Alam, Mohammad Mamun, et al.
Publicado: (2023)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
por: Patocka, Jiri, et al.
Publicado: (2021)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing
por: Fidan, Ozkan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cs7vgad42n06j21j2g1tsjp98